Navigation Links
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain

ROSWELL, Ga., March 1, 2013 /PRNewswire/ -- Kimberly-Clark today announced the publication of two separate studies that achieved positive outcomes following use of cooled radiofrequency (RF) to treat discogenic and sacroiliac joint (SIJ) pain in the low back. The studies evaluated Kimberly-Clark's TransDiscal Cooled Radiofrequency System and SInergy Cooled Radiofrequency System and demonstrated that both treatment options provided patients who suffer from chronic low back pain with much-needed pain relief and improved quality of life benefits. Results were published in Pain Medicine, the official journal of the American Academy of Pain Medicine, the Faculty of Pain Medicine of the Australian and New Zealand College of Anesthetists, and the International Spine Intervention Society.


Dr. Leonardo Kapural of Carolinas Pain Institute and Wake Forest Brookstown Pain Center in Winston-Salem, N.C., led the first-of-its-kind double-blinded randomized controlled trial study of 59 patients with 29 randomized to intradiscal biacuplasty (IDB) and 30 to the control group. Participating patients had a history of chronic low back pain persisting six months or longer. This type of pain is extremely debilitating, and it dramatically limits an individual's everyday activities such as sitting and driving. At the six-month follow-up, patients treated with Kimberly-Clark's TransDiscal Cooled RF System reported significantly greater improvements in restoration of physical function, and a decrease in pain, disability and opioid usage compared to patients in the control group. The study was conducted at the Department of Pain Management at the Cleveland Clinic in Cleveland, Ohio, and the Center for Clinical Research at Carolina's Pain Institute in Winston-Salem.

"Discogenic low back pain accounts for the majority of chronic low back pain. Traditional treatment options include pharmacologic, physiotherapy and surgical options such as spinal fusion or artificial disc replacement. These data are particularly encouraging because there is now additional, compelling evidence to suggest a minimally-invasive approach, such as cooled radiofrequency, can provide sustained relief to a carefully selected group of patients," said lead clinical investigator Leonardo Kapural, M.D., Ph.D. "In this study, patients treated with the TransDiscal Cooled RF System experienced clinically significant improvements in physical function compared to those in the control group."

In the same edition of Pain Medicine, a retrospective chart review found the use of cooled RF to be significantly effective for the treatment of SIJ low back pain. The European study, led by Dr. Wolfgang Stelzer of the Medical University of Vienna, Austria, examined the electronic records of 126 patients treated with Kimberly-Clark's SInergy Cooled RF System for SIJ pain. The retrospective chart review showed promising, durable improvements in pain, quality of life and reduction in medication usage.

At the one-year follow-up, 67 percent of patients stopped or decreased use of opioids, 48 percent of patients reported significant reduction in pain scores and 85 percent stated quality of life was improved or much improved. In some patients, relief was maintained up to 20 months.

These results echo published study findings from Dr. Nilesh Patel of Advanced Pain Management in Green Bay, Wis., in which patients treated with the SInergy Cooled RF System showed significant improvements in pain, disability and quality-of-life outcomes at the three-month mark. Durability of relief was maintained at the nine-month follow-up and 59 percent achieved treatment success[i].

Low back pain is the second most common cause of disability in U.S. adults[ii] and a common reason for lost work days[iii], [iv]. Cooled RF is a minimally-invasive non-pharmacological treatment option for those suffering from low back pain. RF energy heats the nerve tissue while circulating water moderates the temperature in close proximity to the electrode. This combination creates large volume lesions without excessive heating at the electrode. Patients are typically placed under little-to-no sedation and are released the same day.

"The promising results from these two studies further validate the effectiveness and role of cooled radiofrequency as a minimally-invasive treatment option for low back pain," said Lisa Kudlacz , General Manager, Global Interventional Pain Management, Kimberly-Clark Health Care. "Patients with difficult-to-treat, chronic low back pain have an option that has demonstrable benefits — reduction in medication usage, significant improvement in quality of life and improved functionality — to get back to their active lifestyles."

Kimberly-Clark in the Healthcare Environment

Around the world, medical professionals turn to Kimberly-Clark for a wide portfolio of solutions that improve the health, hygiene and well-being of their patients and staff. As part of their healing mission, caregivers rely on Kimberly-Clark to deliver clinical solutions, hygiene & cleaning offerings, and educational resources that they can depend on to prevent, diagnose and manage a wide variety of healthcare-associated infections. This more than $1 billion global enterprise of Kimberly-Clark Corporation holds the No. 1 or No. 2 market share position in several categories, including infection control solutions, surgical solutions, pain management, hygiene solutions and digestive health. And throughout the care continuum, patients and staff alike trust Kimberly-Clark medical supplies and devices, KLEENEX tissues, KLEENEX & SCOTT skin care products and SCOTT towels for day-to-day needs. For more information, visit and

About Kimberly-Clark
Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 175 countries. Every day, nearly a quarter of the world's population trust K-C's brands and the solutions they provide to enhance their health, hygiene and well-being. With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds the No. 1 or No. 2 share position in more than 80 countries. To keep up with the latest K-C news and to learn more about the company's 141-year history of innovation, visit                                                                                      

[i] Patel, N., A Randomized, Placebo-Controlled Study to Assess the Efficacy of Lateral Branch Neurotomy for Chronic Sacroiliac Joint Pain., Pain Medicine, March 2012, V. 13, Issue 3, pages 383–398. 

[ii] From the Centers for Disease Control and Prevention, Prevalence of disabilities and associated health conditions among adults—United States, 1999. JAMA 2001;285 (12) 1571- 1572

[iii] Stewart  WFRicci  JAChee  EMorganstein  DLipton  R Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290 (18) 2443- 2454

[iv] Ricci  JAStewart  WFChee  ELeotta  CFoley  KHochberg  MC Back pain exacerbations and lost productive time costs in United States workers. Spine 2006;31 (26) 3052- 3060

SOURCE Kimberly-Clark
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
2. First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies
3. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
4. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
5. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
8. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
9. Pulse Oximetry Screening Hailed as the New Milestone to Combat Critical Congenital Heart Disease - Signal Extraction Technology Leading the Way in Large, Independent Clinical Studies
10. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  The ... norm in U.S. medical imaging is on ... popular accountable care payer-provider contracts are set ... in their wake, alter provider-vendor relationships. The ... will push forward new purchasing frameworks in ...
(Date:11/30/2015)... , Nov. 30, 2015 Oramed Pharmaceuticals Inc. ... on the development of oral drug delivery systems, announced ... valued at up to $50,000,000 with Hefei Tianhui Incubator of Technologies Co., ... insulin capsule, ORMD-0801, in China , ... Macau . The agreements were signed at the ...
(Date:11/30/2015)... Nov. 30, 2015 iCAD, Inc. (Nasdaq: ... feature its latest solutions for advanced image analysis ... cancer at the Radiological Society of North American ... from November 29 to December 4, ... including iReveal®, an automated breast density assessment solution, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... PYA’s latest white paper, “ PYA ... main “pain point” for merging or aligning healthcare provider organizations—when mergers and other ... This quick-read guidance suggests that failing to recognize the power of an ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of ... SACC-USA . Gary has spent a significant amount of time in Sweden since ...
(Date:12/1/2015)... ... , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won ... order will be from the China Disabled Persons’ Federation, a central government association, for ... for children and adults suffering from severe and profound hearing loss . The ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... on receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This ... patient care experience, and propose exciting enhancements to the medical landscape. , The ...
(Date:11/30/2015)... ... 2015 , ... Third Molar SEO , one of ... launched a sleek, mobile-ready and user-centric redesigned website. , Vivek Srivastava, founder and ... the benefits that its SEO services provide to dentists and why Third Molar ...
Breaking Medicine News(10 mins):